gentleMACS Octo Dissociator with Heaters
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), specifically the NATIONAL INSTITUTES OF HEALTH OLAO, has issued a Notice of Intent to award a Firm-Fixed-Price Purchase Order to Miltenyi Biotec, Inc. for a gentleMACS Octo Dissociator with Heaters. This instrument is crucial for ongoing experimental studies within the Womens Malignancies Branch (WMB) in Bethesda, MD, focusing on aggressive breast cancer types.
Purpose & Scope
The gentleMACS Octo Dissociator with Heaters is essential for generating viable single-cell suspensions from complex tissues, a critical step for downstream research applications in the WMB's studies on aggressive breast cancer. This notice is not a request for competitive quotes but an announcement of the agency's intent to procure this specific item from a sole source.
Contract Details
- Type: Firm-Fixed-Price Purchase Order
- Anticipated Award: Approximately ten (10) days after the notice date.
- Product Service Code: 6640 (Laboratory Equipment And Supplies)
- Place of Performance: Bethesda, MD 20892, United States
Eligibility & Response
While this is not a competitive solicitation, small businesses (including 8(a), service-disabled veteran owned, HUBZone, small disadvantaged, veteran-owned, and women-owned small businesses) are invited to submit a written capability statement. This statement should demonstrate their ability to fulfill the requirement. The Government will review these responses to determine if the proposed award should be competed.
Submission & Deadline
- Submission Method: Email capability statements to David Shen at david.shen@nih.gov.
- Response Due: No later than 11:00 p.m. EDT on June 18, 2026.
- Published Date: June 9, 2026
Additional Notes
The Government reserves the discretion to compete this award based on the capability statements received.